Dr. Scott Gottlieb informed CNBC on Friday he believes america could battle to achieve “true herd immunity” to Covid, suggesting coronavirus infections will likely be round within the years forward.

Nonetheless, the previous commissioner of the U.S. Meals and Drug Administration careworn that new instances alone shouldn’t be the metric receiving essentially the most focus as extra individuals are vaccinated in opposition to Covid.

“I do not assume we must be eager about reaching herd immunity. I do not know that we ever obtain true herd immunity, the place this virus simply stops circulating,” Gottlieb mentioned on “Closing Bell.” “I believe it is at all times going to flow into at a low degree. That must be the purpose, to maintain the extent of virus down.”

Gottlieb, who serves on the board of Covid vaccine maker Pfizer, mentioned he expects the U.S. to see vital progress towards that purpose within the coming weeks.

“I believe that we’re going to get to some extent this summer season the place the circulation of this virus goes to be extraordinarily low. We’re most likely going to see instances begin to collapse sooner or later in Might, fairly quickly. We’re seeing it already in elements of the nation,” Gottlieb mentioned.

Even so, Gottlieb mentioned, the U.S. may degree off someplace round 5,000 to 10,000 new coronavirus instances per day this summer season, partly attributable to how commonplace Covid testing has develop into. “We’ll choose up quite a lot of asymptomatic and mildly symptomatic an infection,” he mentioned.

“I believe the underside line is that the vulnerability of the American inhabitants is being dramatically decreased because of vaccination, and that is actually what we have to concentrate on,” mentioned Gottlieb, who led the FDA from 2017 to 2019 within the Trump administration.

“We should not focus simply on instances alone. There will likely be instances, however we must always concentrate on how many individuals are being hospitalized and getting sick from this virus, and that is going to dramatically decline as we roll out the vaccines,” he mentioned.

Public well being specialists have careworn all through the pandemic that as extra folks in a inhabitants have immunity safety for a selected virus, the much less readily it is going to unfold. Nonetheless, whereas vaccines have been shown to reduce transmission, Gottlieb is not the first to suggest reaching sturdy herd immunity for Covid is prone to be difficult.

White Home chief medical advisor Dr. Anthony Fauci has estimated that 75% to 85% of the inhabitants being vaccinated in opposition to Covid would create an “umbrella” of immunity. “That may be capable to defend even the vulnerables who haven’t been vaccinated or these wherein the vaccine has not been efficient,” he informed CNBC in December shortly after the FDA granted Pfizer’s vaccine emergency use authorization.

Roughly 41% of the U.S. inhabitants has now acquired at the least one Covid vaccine dose and 27.5% is absolutely vaccinated, based on the latest figures from the Facilities for Illness Management and Prevention. Greater than 220 million complete doses have been administered, CDC information reveals.

Gottlieb has beforehand mentioned the U.S. may, in idea, get to some extent the place Covid is eradicated like other diseases resembling polio and smallpox. “It is attainable. We aren’t ready to do it and take the collective motion that it should require,” he informed CNBC on April 16.

“It’ll require folks exercising some civic advantage to get vaccinated even when they individually really feel they’re at low danger of the an infection,” he mentioned. “As a result of even when they’re personally low danger they will nonetheless get and transmit the an infection, and you may’t eradicate a illness the place you will have a big contingent of people who find themselves going to proceed to catch it and transmit it.”

Disclosure: Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer, genetic testing start-up Tempus, health-care tech firm Aetion Inc. and biotech firm Illumina. He additionally serves as co-chair of Norwegian Cruise Line Holdings′ and Royal Caribbean’s “Wholesome Sail Panel.”